⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
ControlledPhenethylamine

25I-NBOMe

Formula Pending

Molecular Mass
N/A
CAS Registry
N/A
Risk Class
LOW
Last Audit
Jan 1, 2024

Research Abstract

Potent serotonergic psychedelic, 5-HT2A agonist

25I-NBOMe is a phenethylamine asset inside marketed initiatives, optimized for therapeutic and clinical research.

The dossier currently sits in controlled with a low risk rating, meaning it is cleared for baseline monitoring protocols.

Supply records cite CAS N/A with updates logged 2024-01-01.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

TherapeuticClinical Research

Nomenclature

25I-NBOMe

Reference Material

  1. [1] Anubis Compound Registry • CAS N/A
  2. [2] Operations Pulse • Marketed
  3. [3] Risk Governance Ledger • LOW clearance for 25I-NBOME